
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
---|---|---|---|---|---|---|
Revenue | $12.5B | $12.9B | $14.5B | $14.7B | $13.6B | |
Revenue Growth (YoY) | 31.83% | 3.15% | 13.09% | 1.03% | -7.17% | |
Cost of Revenues | $9.9B | $10.1B | $11.7B | $12B | $10.9B | |
Gross Profit | $2.5B | $2.7B | $2.8B | $2.7B | $2.7B | |
Gross Profit Margin | 20.34% | 21.24% | 19.39% | 18.55% | 19.88% | |
R&D Expenses | $97M | $100M | $96M | $101M | $106M | |
Selling, General & Admin | $1.4B | $1.3B | $1.3B | $1.2B | $1.3B | |
Other Inc / (Exp) | -$99M | -$83M | -$223M | $106M | -$94M | |
Operating Expenses | $1.4B | $1.3B | $1.3B | $1.3B | $1.4B | |
Operating Income | $1.1B | $1.4B | $1.5B | $1.4B | $1.3B | |
Net Interest Expenses | $185M | $139M | $135M | $259M | $310M | |
EBT. Incl. Unusual Items | $825M | $1.2B | $1.1B | $1.3B | $907M | |
Earnings of Discontinued Ops. | -$8M | -- | -- | -- | -- | |
Income Tax Expense | $187M | $261M | $300M | $193M | $163M | |
Net Income to Company | $616M | $951M | $815M | $1.1B | $740M | |
Minority Interest in Earnings | -$4M | -$12M | -$10M | -$10M | -$10M | |
Net Income to Common Excl Extra Items | $612M | $939M | $805M | $1B | $730M | |
Basic EPS (Cont. Ops) | $0.38 | $0.60 | $0.53 | $0.71 | $0.51 | |
Diluted EPS (Cont. Ops) | $0.38 | $0.60 | $0.53 | $0.71 | $0.51 | |
Weighted Average Basic Share | $1.6B | $1.6B | $1.5B | $1.5B | $1.4B | |
Weighted Average Diluted Share | $1.6B | $1.6B | $1.5B | $1.5B | $1.4B | |
EBITDA | $1.7B | $1.9B | $1.9B | $2.1B | $1.9B | |
EBIT | $1B | $1.3B | $1.3B | $1.5B | $1.3B | |
Revenue (Reported) | $12.5B | $12.9B | $14.5B | $14.7B | $13.6B | |
Operating Income (Reported) | $1.1B | $1.4B | $1.5B | $1.4B | $1.3B | |
Operating Income (Adjusted) | $1B | $1.3B | $1.3B | $1.5B | $1.3B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $3.2B | $3.7B | $3.7B | $3.4B | $3.3B | |
Revenue Growth (YoY) | 2.1% | 15.62% | -1.11% | -6.98% | -2.29% | |
Cost of Revenues | $2.5B | $3B | $3B | $2.7B | $2.7B | |
Gross Profit | $682M | $731M | $673M | $692M | $654M | |
Gross Profit Margin | 21.27% | 19.71% | 18.35% | 20.29% | 19.62% | |
R&D Expenses | $25M | $24M | $27M | $25M | $27M | |
Selling, General & Admin | $325M | $326M | $317M | $330M | $303M | |
Other Inc / (Exp) | $25M | -$4M | -$48M | -$28M | -$33M | |
Operating Expenses | $333M | $353M | $341M | $355M | $309M | |
Operating Income | $349M | $378M | $332M | $337M | $345M | |
Net Interest Expenses | $33M | $31M | $71M | $79M | $75M | |
EBT. Incl. Unusual Items | $341M | $343M | $213M | $230M | $237M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $71M | $72M | $34M | $40M | $40M | |
Net Income to Company | $270M | $271M | $179M | $189M | $197M | |
Minority Interest in Earnings | -$3M | -$2M | -$2M | -$2M | -$1M | |
Net Income to Common Excl Extra Items | $267M | $269M | $177M | $187M | $196M | |
Basic EPS (Cont. Ops) | $0.17 | $0.18 | $0.12 | $0.13 | $0.14 | |
Diluted EPS (Cont. Ops) | $0.17 | $0.18 | $0.12 | $0.13 | $0.14 | |
Weighted Average Basic Share | $1.5B | $1.5B | $1.5B | $1.4B | $1.4B | |
Weighted Average Diluted Share | $1.6B | $1.5B | $1.5B | $1.4B | $1.4B | |
EBITDA | $516M | $526M | $443M | $472M | $454M | |
EBIT | $377M | $379M | $299M | $319M | $322M | |
Revenue (Reported) | $3.2B | $3.7B | $3.7B | $3.4B | $3.3B | |
Operating Income (Reported) | $349M | $378M | $332M | $337M | $345M | |
Operating Income (Adjusted) | $377M | $379M | $299M | $319M | $322M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $12.6B | $14.1B | $14.9B | $13.8B | $13.5B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $9.8B | $11.3B | $12.1B | $11.1B | $10.8B | |
Gross Profit | $2.7B | $2.8B | $2.8B | $2.7B | $2.7B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $97M | $98M | $100M | $105M | $108M | |
Selling, General & Admin | $1.3B | $1.3B | $1.3B | $1.3B | $1.2B | |
Other Inc / (Exp) | -$70M | -$83M | -$41M | -$141M | -$88M | |
Operating Expenses | $1.4B | $1.3B | $1.3B | $1.4B | $1.3B | |
Operating Income | $1.3B | $1.5B | $1.5B | $1.3B | $1.4B | |
Net Interest Expenses | $148M | $136M | $224M | $302M | $300M | |
EBT. Incl. Unusual Items | $1.1B | $1.2B | $1.2B | $841M | $1B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $251M | $270M | $229M | $175M | $197M | |
Net Income to Company | $869M | $962M | $986M | $663M | $818M | |
Minority Interest in Earnings | -$6M | -$11M | -$9M | -$10M | -$11M | |
Net Income to Common Excl Extra Items | $863M | $951M | $977M | $653M | $807M | |
Basic EPS (Cont. Ops) | $0.55 | $0.62 | $0.66 | $0.45 | $0.56 | |
Diluted EPS (Cont. Ops) | $0.55 | $0.62 | $0.65 | $0.45 | $0.56 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $1.9B | $2B | $2.1B | $1.8B | $1.9B | |
EBIT | $1.3B | $1.4B | $1.5B | $1.2B | $1.4B | |
Revenue (Reported) | $12.6B | $14.1B | $14.9B | $13.8B | $13.5B | |
Operating Income (Reported) | $1.3B | $1.5B | $1.5B | $1.3B | $1.4B | |
Operating Income (Adjusted) | $1.3B | $1.4B | $1.5B | $1.2B | $1.4B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $9.4B | $10.6B | $11B | $10.1B | $9.9B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $7.4B | $8.6B | $9B | $8.1B | $8B | |
Gross Profit | $2B | $2B | $2B | $2B | $1.9B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $74M | $72M | $76M | $80M | $82M | |
Selling, General & Admin | $962M | $942M | $917M | $931M | $913M | |
Other Inc / (Exp) | -$15M | -$15M | $167M | -$80M | -$74M | |
Operating Expenses | $1B | $1B | $982M | $1.1B | $946M | |
Operating Income | $978M | $1B | $1B | $901M | $993M | |
Net Interest Expenses | $103M | $100M | $189M | $232M | $222M | |
EBT. Incl. Unusual Items | $860M | $899M | $999M | $589M | $697M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $187M | $196M | $125M | $107M | $141M | |
Net Income to Company | $692M | $703M | $874M | $479M | $557M | |
Minority Interest in Earnings | -$8M | -$7M | -$6M | -$6M | -$7M | |
Net Income to Common Excl Extra Items | $684M | $696M | $868M | $473M | $550M | |
Basic EPS (Cont. Ops) | $0.44 | $0.46 | $0.59 | $0.33 | $0.38 | |
Diluted EPS (Cont. Ops) | $0.44 | $0.46 | $0.58 | $0.33 | $0.38 | |
Weighted Average Basic Share | $4.7B | $4.6B | $4.4B | $4.3B | $4.3B | |
Weighted Average Diluted Share | $4.7B | $4.6B | $4.4B | $4.3B | $4.3B | |
EBITDA | $1.4B | $1.5B | $1.7B | $1.3B | $1.3B | |
EBIT | $973M | $1B | $1.2B | $852M | $949M | |
Revenue (Reported) | $9.4B | $10.6B | $11B | $10.1B | $9.9B | |
Operating Income (Reported) | $978M | $1B | $1B | $901M | $993M | |
Operating Income (Adjusted) | $973M | $1B | $1.2B | $852M | $949M |
Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $743M | $850M | $775M | $689M | $588M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $1.6B | $1.9B | $1.9B | $1.9B | $1.8B | |
Inventory | $1.8B | $2B | $2.4B | $2.2B | $2B | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $344M | $561M | $512M | $531M | $500M | |
Total Current Assets | $4.5B | $5.3B | $5.9B | $5.3B | $5B | |
Property Plant And Equipment | $4.1B | $4.3B | $4.2B | $4.3B | $4.3B | |
Long-Term Investments | $78M | -- | -- | -- | -- | |
Goodwill | $5.3B | $5.4B | $5.3B | $5.4B | $5.3B | |
Other Intangibles | $2B | $1.8B | $1.7B | $1.5B | $1.4B | |
Other Long-Term Assets | $177M | $184M | $206M | $309M | $311M | |
Total Assets | $16.4B | $17.2B | $17.4B | $17B | $16.5B | |
Accounts Payable | $2.2B | $2.6B | $3.1B | $2.7B | $2.6B | |
Accrued Expenses | $477M | $523M | $471M | $396M | $399M | |
Current Portion Of Long-Term Debt | $11M | $5M | $14M | $13M | $15M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $1.1B | $1.1B | $1.4B | $1.3B | $1.2B | |
Total Current Liabilities | $4B | $4.3B | $5.1B | $4.5B | $4.3B | |
Long-Term Debt | $6B | $6.2B | $6.3B | $6.7B | $6.6B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $11.8B | $12.4B | $13.3B | $12.9B | $12.6B | |
Common Stock | $16M | $15M | $15M | $14M | $14M | |
Other Common Equity Adj | -$1B | -$766M | -$880M | -$862M | -$1B | |
Common Equity | $4.6B | $4.8B | $4.1B | $4B | $3.9B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $61M | $57M | $59M | $64M | $72M | |
Total Equity | $4.7B | $4.8B | $4.1B | $4.1B | $4B | |
Total Liabilities and Equity | $16.4B | $17.2B | $17.4B | $17B | $16.5B | |
Cash and Short Terms | $743M | $850M | $775M | $689M | $588M | |
Total Debt | $6.2B | $6.3B | $6.5B | $6.7B | $6.7B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $690M | $1.1B | $564M | $457M | $2B | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $1.8B | $2.1B | $2B | $1.9B | $2B | |
Inventory | $1.9B | $2.4B | $2.4B | $2.1B | $2.1B | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $429M | $583M | $570M | $552M | $546M | |
Total Current Assets | $4.8B | $6.2B | $5.6B | $5B | $6.7B | |
Property Plant And Equipment | $4.2B | $4.3B | $4.3B | $4.3B | $4.2B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $5.4B | $5.4B | $5.3B | $5.4B | $5.3B | |
Other Intangibles | $1.9B | $1.7B | $1.5B | $1.4B | $1.3B | |
Other Long-Term Assets | $168M | $227M | $300M | $330M | $326M | |
Total Assets | $16.6B | $18B | $17.3B | $16.7B | $18B | |
Accounts Payable | $2B | $2.8B | $2.5B | $2.2B | $2.3B | |
Accrued Expenses | $457M | $412M | $359M | $338M | $315M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $1.1B | $1.1B | $1.3B | $1.2B | $1.1B | |
Total Current Liabilities | $3.7B | $4.4B | $4.4B | $3.9B | $3.9B | |
Long-Term Debt | $6.5B | $7.2B | $6.8B | $7.1B | $8.6B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $11.9B | $13.4B | $13B | $12.7B | $14.2B | |
Common Stock | $15M | $15M | $15M | $14M | $14M | |
Other Common Equity Adj | -$899M | -$807M | -$857M | -$868M | -$1.1B | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $58M | $60M | $60M | $64M | $8M | |
Total Equity | $4.7B | $4.6B | $4.3B | $4B | $3.9B | |
Total Liabilities and Equity | $16.6B | $18B | $17.3B | $16.7B | $18B | |
Cash and Short Terms | $690M | $1.1B | $564M | $457M | $2B | |
Total Debt | $6.6B | $7.2B | $7B | $7.2B | $8.8B |
Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $616M | $951M | $815M | $1.1B | $740M | |
Depreciation & Amoritzation | $652M | $574M | $625M | $586M | $595M | |
Stock-Based Compensation | $34M | $58M | $63M | $54M | $32M | |
Change in Accounts Receivable | $133M | -$189M | -$272M | $93M | -$43M | |
Change in Inventories | $26M | -$112M | -$626M | $248M | $95M | |
Cash From Operations | $1.4B | $1.5B | $1.5B | $1.3B | $1.3B | |
Capital Expenditures | $400M | $468M | $527M | $526M | $492M | |
Cash Acquisitions | $425M | $209M | -$13M | $188M | -$23M | |
Cash From Investing | $38M | -$233M | -$527M | -$309M | -$476M | |
Dividends Paid (Ex Special Dividend) | -$761M | -$742M | -$732M | -$723M | -$722M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $3.2B | $790M | $1.1B | $522M | $1B | |
Long-Term Debt Repaid | -$4.2B | -$532M | -$1.2B | -$341M | -$27M | |
Repurchase of Common Stock | -$604M | -$359M | -$744M | -$653M | -$81M | |
Other Financing Activities | $4M | -$8M | -- | -- | -- | |
Cash From Financing | -$1.2B | -$1.2B | -$891M | -$1B | -$857M | |
Beginning Cash (CF) | $602M | $743M | $850M | $850M | $689M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $186M | $49M | $33M | -$73M | -$12M | |
Ending Cash (CF) | $743M | $850M | $775M | $689M | $588M | |
Levered Free Cash Flow | $984M | $993M | $999M | $735M | $829M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $270M | $271M | $179M | $189M | $197M | |
Depreciation & Amoritzation | $139M | $147M | $144M | $153M | $132M | |
Stock-Based Compensation | $16M | $16M | $13M | $14M | $12M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $175M | $266M | $184M | $150M | $117M | |
Capital Expenditures | $117M | $118M | $132M | $113M | $117M | |
Cash Acquisitions | $76M | -$1M | -$45M | -$1M | -- | |
Cash From Investing | -$39M | -$118M | -$173M | -$113M | -$115M | |
Dividends Paid (Ex Special Dividend) | -$182M | -$182M | -$180M | -$181M | -$184M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $176M | $666M | $298M | -$322M | $1.9B | |
Long-Term Debt Repaid | $45M | -$69M | -$241M | $44M | $6M | |
Repurchase of Common Stock | -$233M | -$128M | -$160M | -- | -$1M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$192M | $287M | -$282M | -$15M | $1.6B | |
Beginning Cash (CF) | $755M | $626M | $837M | $430M | $445M | |
Foreign Exchange Rate Adjustment | -$9M | $16M | -$2M | $5M | $7M | |
Additions / Reductions | -$56M | $435M | -$271M | $22M | $1.6B | |
Ending Cash (CF) | $690M | $1.1B | $564M | $457M | $2B | |
Levered Free Cash Flow | $58M | $148M | $52M | $37M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $869M | $962M | $986M | $663M | $818M | |
Depreciation & Amoritzation | $579M | $627M | $574M | $606M | $546M | |
Stock-Based Compensation | $54M | $61M | $58M | $32M | $42M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $1.5B | $1.4B | $1.3B | $1.3B | $1.2B | |
Capital Expenditures | $422M | $506M | $536M | $502M | $494M | |
Cash Acquisitions | $214M | -$17M | $221M | -$57M | $102M | |
Cash From Investing | -$194M | -$501M | -$293M | -$529M | -$356M | |
Dividends Paid (Ex Special Dividend) | -$743M | -$736M | -$727M | -$720M | -$730M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $682M | $2.1B | $46M | -$276M | $3.2B | |
Long-Term Debt Repaid | -$1.9B | -$1B | -$833M | -$31M | -$11M | |
Repurchase of Common Stock | -$423M | -$607M | -$609M | -$313M | -$53M | |
Other Financing Activities | -$8M | -- | -- | -- | -- | |
Cash From Financing | -$1.2B | -$526M | -$1.3B | -$859M | $797M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $90M | $406M | -$417M | -$78M | $1.7B | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $1.1B | $927M | $730M | $808M | $725M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $692M | $703M | $874M | $479M | $557M | |
Depreciation & Amoritzation | $426M | $479M | $428M | $448M | $399M | |
Stock-Based Compensation | $44M | $47M | $42M | $20M | $30M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $617M | $589M | $329M | $378M | $276M | |
Capital Expenditures | $335M | $373M | $382M | $358M | $360M | |
Cash Acquisitions | $214M | -$12M | $222M | -$23M | $102M | |
Cash From Investing | -$115M | -$383M | -$149M | -$369M | -$249M | |
Dividends Paid (Ex Special Dividend) | -$556M | -$550M | -$545M | -$542M | -$550M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $505M | $1.8B | $798M | -- | $2.2B | |
Long-Term Debt Repaid | -$246M | -$752M | -$337M | -$27M | -$11M | |
Repurchase of Common Stock | -$308M | -$556M | -$421M | -$81M | -$53M | |
Other Financing Activities | -$7M | -- | -- | -- | -$11M | |
Cash From Financing | -$601M | $52M | -$372M | -$206M | $1.4B | |
Beginning Cash (CF) | $2.3B | $2.1B | $2.2B | $1.6B | $1.5B | |
Foreign Exchange Rate Adjustment | $46M | -$31M | -$94M | -$35M | -$18M | |
Additions / Reductions | -$99M | $258M | -$192M | -$197M | $1.5B | |
Ending Cash (CF) | $2.2B | $2.3B | $2B | $1.4B | $2.9B | |
Levered Free Cash Flow | $282M | $216M | -$53M | $20M | -$84M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.